To amend the Federal Food, Drug, and Cosmetic Act with respect to human drug compounding and drug supply chain security, and for other purposes.
Sponsor and status
Sponsor. Representative for Michigan's 6th congressional district. Republican.
Last Updated: Nov 21, 2013
Length: 54 pages
113th Congress, 2013–2015
Enacted — Signed by the President on Nov 27, 2013
This bill was enacted after being signed by the President on November 27, 2013.
What legislators are saying
“Latta Comments on President Signing Legislation to Combat Counterfeit Pharmaceuticals”
— Rep. Robert Latta [R-OH5] (Co-sponsor) on Nov 27, 2013
“Cummings Applauds Passage of Bipartisan Legislation to Improve Pharmaceutical Drug Distribution System: Bill Includes Cummings’ Provisions to Combat Unethical “Gray Market” Drug Distributors”
— Rep. Elijah Cummings [D-MD7] on Sep 29, 2013
This bill incorporates provisions from:
S. 959: Pharmaceutical Quality, Security, and Accountability Act
Ordered Reported on May 22, 2013. 70% incorporated. (compare text)
H.R. 1919: Safeguarding America’s Pharmaceuticals Act of 2013
Passed House (Senate next) on Jun 3, 2013. 33% incorporated. (compare text)
Jun 3, 2013
Source Bill — Passed House (Senate next)
This activity took place on a related bill, H.R. 1919 (113th), possibly in lieu of similar activity on H.R. 3204 (113th).
Sep 27, 2013
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Sep 28, 2013
Passed House (Senate next)
The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.
Nov 18, 2013
The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by Voice Vote so no record of individual votes was made.
Nov 27, 2013
Enacted — Signed by the President
The President signed the bill and it became law.
H.R. 3204 (113th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 113th Congress, which met from Jan 3, 2013 to Jan 2, 2015. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 3204 — 113th Congress: Drug Quality and Security Act. Retrieved from https://www.govtrack.us/congress/bills/113/hr3204
“H.R. 3204 — 113th Congress: Drug Quality and Security Act.” www.GovTrack.us. 2013. October 17, 2019 <https://www.govtrack.us/congress/bills/113/hr3204>
Drug Quality and Security Act, Pub. L. No. 113-54, H.R. 3204, 113th Cong. (2013).
|title=H.R. 3204 (113th)
|accessdate=October 17, 2019
|author=113th Congress (2013)
|date=September 27, 2013
|quote=Drug Quality and Security Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.